Health Sciences Group, Inc. 

(Public, OTC:HESG)   Watch this stock   
Find more results for HESG

Key stats and ratios

Q3 (Sep '06) 2005
Net profit margin -19000.00% -9293.33%
Operating margin -18220.00% -13200.00%
EBITD margin - -12735.00%
Return on average assets -101.79% -130.36%
Return on average equity - -
Employees 2 -

Address

Howard Hughes Center 6080 Center Drive 6th. Floor
Los Angeles, CA 90045
United States - Map
+1-310-2426700 (Phone)

Website links

Health Sciences Group, Inc. discussions

  View all discussions »

Description

Health Sciences Group, Inc. identifies, develops and commercializes products and functional food ingredients derived from natural sources to provide consumers and healthcare professionals with preventive healthcare alternatives. The Company has two operating subsidiaries: BioSelect Innovations, Inc. and Swiss Research, Inc. BioSelect Innovations has developed a number of product formulations. These patents address the integration of selective traditional over-the-counter generic drugs with complementary alternative medications, such as vitamins, herbs and other natural nutraceutical supplements. Swiss Research is a diet and nutrition products company, which markets and sells Shugr, a zero-calorie and diabetic safe sugar substitute with the look, taste and baking qualities of cane sugar. The Company will launch its new product, Sequesterol Advance Cardio Formula in April 2006.

Officers and directors

Duke Best
Controller
Age: 33
William T. Walker Jr.
Director
Age: 73
Sid L. Anderson
Director
Age: 58
Anthony DeBella
Director